Dyadic
DYAIPre-clinicalDyadic is a global biotechnology company focused on the scalable production of high-value, precision-engineered functional input proteins for use in life sciences, food and nutrition, and industrial biotechnology applications.
Market Cap
$203.4M
DYAI · Stock Price
USD 5.62+3.98 (+242.68%)
Historical price data
About
Dyadic is a global biotechnology company focused on the scalable production of high-value, precision-engineered functional input proteins for use in life sciences, food and nutrition, and industrial biotechnology applications.
Company Info
TypePublic
LocationUnited States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile